Zevra Therapeutics, Inc. (ZVRA) Insider Ownership

Historic Insider Ownership Trends

ZVRA's three largest insider shareholders as of March 23, 2026 are Samuel J Braun (TenPercentOwner, 3.07Mn shares), Neil F. Mcfarlane (President And Ceo, 387.23K shares), R. Laduane Clifton (Other, 143.51K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Samuel J Braun 3,070,000 0 17 May, 2021
Neil F. Mcfarlane President And Ceo 387,225 0 10 Feb, 2026
R. Laduane Clifton 143,515 0 07 Jan, 2026
Joshua Schafer Cco 62,278 0 04 Feb, 2026
Travis C Mickle President Ceo 39,521 11,034 25 May, 2022
Rahsaan Thompson Chief Legal Compliance 49,919 0 02 Feb, 2026
John B Bode 45,000 0 20 Aug, 2025
Richard W Pascoe Chief Executive Officer 29,973 0 13 Mar, 2023
Timothy J. Sangiovanni Svp, Finance Corp Controller 29,590 0 04 Feb, 2026
Thomas Anderson 20,000 0 16 Jul, 2024
Alvin Shih 20,000 0 15 Sep, 2025
Matthew R Plooster 18,500 0 13 Mar, 2023
David S Tierney 10,835 0 13 Mar, 2023
Adrian W Quartel Chief Medical Officer 9,723 0 02 Feb, 2026
Matthew R Plooster 7,500 0 18 May, 2022
Tamara A Favorito 3,894 0 16 Sep, 2025
Corey Michael Watton 1,800 0 31 Mar, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
18 Mar, 2026 Justin A Renz Stock Option (right to buy) A 300,000 $0.00 300,000 D A
07 Feb, 2026 Neil F. Mcfarlane Common Stock A 37,500 - 401,850 D M
09 Feb, 2026 Neil F. Mcfarlane Common Stock D 14,625 $8.56 387,225 D S
07 Feb, 2026 Neil F. Mcfarlane Restricted Stock Unit D 37,500 $0.00 75,000 D M
03 Feb, 2026 Joshua Schafer Common Stock D 10,500 $9.19 62,278 D S
03 Feb, 2026 Timothy J. Sangiovanni Common Stock D 3,000 $9.18 29,590 D S
30 Jan, 2026 Adrian W Quartel Common Stock A 11,333 - 14,256 D M
31 Jan, 2026 Neil F. Mcfarlane Common Stock A 233,334 - 455,350 D M
30 Jan, 2026 Rahsaan Thompson Common Stock A 11,333 - 53,999 D M
30 Jan, 2026 Timothy J. Sangiovanni Common Stock A 6,333 - 22,674 D M
30 Jan, 2026 Joshua Schafer Common Stock A 11,333 - 40,819 D M
30 Jan, 2026 Rahsaan Thompson Common Stock D 4,080 $8.83 49,919 D S
30 Jan, 2026 Joshua Schafer Common Stock D 3,375 $8.83 37,444 D S
30 Jan, 2026 Timothy J. Sangiovanni Common Stock D 1,750 $8.82 20,924 D S
30 Jan, 2026 Adrian W Quartel Common Stock D 4,533 $8.83 9,723 D S
02 Feb, 2026 Neil F. Mcfarlane Common Stock D 91,000 $9.38 364,350 D S
31 Jan, 2026 Joshua Schafer Common Stock A 35,334 - 72,778 D M
29 Jan, 2026 Rahsaan Thompson Restricted Stock Unit A 37,500 $0.00 37,500 D A
29 Jan, 2026 Neil F. Mcfarlane Restricted Stock Unit A 125,000 $0.00 125,000 D A
31 Jan, 2026 Timothy J. Sangiovanni Common Stock A 11,666 - 32,590 D M